Clinical Trials Browser

Phase 2/3 × OTHER × Methotrexate × Clear all

NCT03117751 2025-12-05

Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma

Phase 2/3 Active not recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06855810 2025-08-26

CCCG-TALL-2025

Phase 2/3 Recruiting

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06882057 2025-08-26

CCCG-LR-B-ALL

Phase 2/3 Recruiting

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01228331 2024-12-11

Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL

Phase 2/3 Completed

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05057130 2024-04-01

Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors

Phase 2/3 Recruiting

Bone Neoplasms, Neoplasms, Connective Tissue, Sarcoma, Osteosarcoma, Neoplasms, Connective and Soft Tissue

NCT00096460 2023-01-05

BMT CTN 0202

Phase 2/3 Terminated

30 enrolled 5 charts

Lymphoma, Follicular

NCT04453345 2020-07-01

TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL

Phase 2/3 Unknown

Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic

NCT03885388 2019-03-21

Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6

Phase 2/3 Unknown

Gestational Trophoblastic Disease, Drug-Related Side Effects and Adverse Reactions

NCT03564704 2018-06-21

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

Phase 2/3 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03553238 2018-06-12

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL

Phase 2/3 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02606539 2017-03-22

SVCGTN

Phase 2/3 Unknown

Gestational Trophoblastic Disease

NCT01204437 2016-02-10

ICE-II

Phase 2/3 Completed

Breast Neoplasms

NCT00795756 2014-10-22

Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic Leukemia

Phase 2/3 Completed

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00003187 2010-02-24

Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

Phase 2/3 Completed

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma